References
COVID-19 infection
ADVERSE EFFECTS, COVID-19 INFECTION
COVID-19-neutralizing antibody titer scores for individual patients at various time periods categorized by COVID-19 infection status and intervention group.Sociodemographic data and clinical characteristics for 73 HD patients included in the study.* Previous COVID-19 infection and vaccination status.NA: not applicable.Neutralization antibody titer scores over time in those with and without Evusheld use.Notes: Q1 = 25th percentile. Q3 = 75th percentile. NAB in scored 1, 2, or 3 if it is <200, 200–800, or >800 AU/mL, respectively.COVID-19 infection after study enrollment.* Adverse effects of Evusheld in the study’s HD patients who received Evusheld.